Noronex Ltd
Noronex Limited engages in the mineral exploration in Australia, Namibia, and Canada. It primarily explores for uranium and copper deposits. The company's flagship project is the Witvlei Copper project in Namibia. The company was formerly known as Lustrum Minerals Limited and changed its name to Noronex Limited in November 2020. Noronex Limited was incorporated in 2015 and is based in Subiaco, Au… Read more
Noronex Ltd (NRX) - Total Liabilities
Latest total liabilities as of June 2025: AU$1.22 Million AUD
Based on the latest financial reports, Noronex Ltd (NRX) has total liabilities worth AU$1.22 Million AUD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Noronex Ltd - Total Liabilities Trend (2016–2025)
This chart illustrates how Noronex Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Noronex Ltd Competitors by Total Liabilities
The table below lists competitors of Noronex Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CASI Pharmaceuticals Inc
NASDAQ:CASI
|
USA | $53.05 Million |
|
NSBBF
OTCQB:NSBBF
|
USA | $56.48 Million |
|
Era Mandiri Cemerlang Tbk PT
JK:IKAN
|
Indonesia | Rp54.14 Billion |
|
Anik Industries Limited
NSE:ANIKINDS
|
India | ₹659.93 Million |
|
Carmell Therapeutics Corporation
NASDAQ:CTCX
|
USA | $7.14 Million |
|
XWELL Inc.
NASDAQ:XWEL
|
USA | $18.68 Million |
|
Wahana Pronatural
JK:WAPO
|
Indonesia | Rp98.34 Billion |
|
Gasporox AB (publ)
ST:GPX
|
Sweden | Skr27.82 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Noronex Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.83 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Noronex Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Noronex Ltd (2016–2025)
The table below shows the annual total liabilities of Noronex Ltd from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$1.22 Million | +61.68% |
| 2024-06-30 | AU$754.42K | +77.71% |
| 2023-06-30 | AU$424.52K | -9.38% |
| 2022-06-30 | AU$468.48K | +80.20% |
| 2021-06-30 | AU$259.97K | +54.22% |
| 2020-06-30 | AU$168.57K | +119.50% |
| 2019-06-30 | AU$76.80K | -42.32% |
| 2018-06-30 | AU$133.15K | +2563.00% |
| 2017-06-30 | AU$5.00K | +488.24% |
| 2016-06-30 | AU$850.00 | -- |